A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study
- DOI
- 10.1371/journal.pone.0285941
- Published
- 2023-05-17
- Container
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0285941,
title = {A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study},
author = {Alireza Mohebbi and Touba Ghorbanzadeh and Shabnam Naderifar and Fattaneh Khalaj and Fatemeh Sana Askari and Ali Salehnia Sammak},
year = {2023},
journal = {PLOS ONE},
doi = {10.1371/journal.pone.0285941},
url = {https://doi.org/10.1371/journal.pone.0285941}
}RIS
TY - JOUR TI - A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study AU - Alireza Mohebbi AU - Touba Ghorbanzadeh AU - Shabnam Naderifar AU - Fattaneh Khalaj AU - Fatemeh Sana Askari AU - Ali Salehnia Sammak PY - 2023 JO - PLOS ONE DO - 10.1371/journal.pone.0285941 UR - https://doi.org/10.1371/journal.pone.0285941 ER -
APA
Mohebbi, A., Ghorbanzadeh, T., Naderifar, S., Khalaj, F., Askari, F. S., & Sammak, A. S. (2023). A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study. PLOS ONE. https://doi.org/10.1371/journal.pone.0285941
Source records
- crossref · retrieved 2026-09-27T01:23:32.280Z